Proportion of Patients With Ductal Carcinoma In Situ That Qualify for Observation Criteria Set Forth by Clinical Trials.
Callie D McAdamsNicholas ClevengerKyra NicholsonCatherine PesceKatherine KopkashElizabeth PoliThomas W SmithKatharine A YaoPublished in: Journal of surgical oncology (2024)
One in five patients diagnosed with DCIS at our institution would qualify for observation with current trial eligibility. Observation of DCIS may have limited impact on all DCIS patients.